Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer S Zalba, AM Contreras, A Haeri, TLM Ten Hagen, I Navarro, G Koning, ... Journal of Controlled Release 210, 26-38, 2015 | 122 | 2015 |
EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model S Zalba, AM Contreras, M Merino, I Navarro, CT De Ilarduya, IF Trocóniz, ... Nanomedicine 11 (5), 465-477, 2016 | 29 | 2016 |
A new immune-nanoplatform for promoting adaptive antitumor immune response M Merino, A Contreras, N Casares, IF Troconiz, TL Ten Hagen, ... Nanomedicine: Nanotechnology, Biology and Medicine 17, 13-25, 2019 | 25 | 2019 |
Correlation between anti-PD-L1 tumor concentrations and tumor-specific and nonspecific biomarkers in a melanoma mouse model AM Contreras, M Merino, M Vasquez, IF Trocóniz, P Berraondo, ... Oncotarget 7 (47), 76891, 2016 | 16 | 2016 |
Quantification of pharmacokinetic profiles of pd-1/pd-l1 antibodies by validated elisas S Zalba, AM Contreras-Sandoval, E Martisova, R Debets, C Smerdou, ... Pharmaceutics 12 (6), 595, 2020 | 11 | 2020 |
Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression A Aiderus, JY Newberg, L Guzman-Rojas, AM Contreras-Sandoval, ... PLoS genetics 17 (8), e1009094, 2021 | 6 | 2021 |
Promoterless Transposon Mutagenesis Drives Solid Cancers via Tumor Suppressor Inactivation A Aiderus, AM Contreras-Sandoval, AL Meshey, JY Newberg, JM Ward, ... Cancers 13 (2), 225, 2021 | 2 | 2021 |
161 Harnessing Sleeping Beauty transposon mutagenesis to model tumor heterogeneity in melanoma preclinical models AM Contreras-Sandoval, MB Mann Journal of Investigative Dermatology 139 (5), S28, 2019 | | 2019 |
Development of an in-vivo platform to evaluate the PK-PD relationship of an anti-PD-L1 mAb in a syngeneic mouse model of melanoma AM Contreras | | 2017 |
Understanding the effect mechanism through the good biomarker: Anti-PD-L1 immunotherapy A Contreras, M Merino, P Berraondo, M Garrido EUROPEAN JOURNAL OF CANCER 55, S13-S14, 2016 | | 2016 |